Food and Drug Administration
Pharma

Regulatory tracker: Braftovi nets colorectal cancer wins abroad

Here, we're tracking the regulatory progress of in-market products, including expansions into key geographies and new indications.
cancer target detection radiopharma radio

Lantheus considers potential $7B Curium buyout proposal: report

May 26, 2026 10:38am
Eliminating KRAS Why targeted protein degraders could redefinewhatspossible in cancer

Eliminating KRAS: How degraders could redefine cancer care

Brought to you by ASTELLAS
Gilead

Gilead's once-rejected hepatitis D med wins FDA nod

May 26, 2026 9:49am
Real-World Evidence in the AI Era What You Can Unlock Depends on What You Build On

RWE in the AI Era: What You Unlock Depends on What You Build On

Brought to you by Flatiron Health
Niowave

Niowave starts building $75M plant to boost radioisotope supply

May 26, 2026 8:35am
More News

AbbVie trims Allergan workforce by 85

May 22, 2026 12:12pm

EU regulator recommends AZ's Etcamah, Novo's Wegovy pill

May 22, 2026 11:58am

AZ, Daiichi's Datroway approved in first-line TNBC

May 22, 2026 11:32am

The Oral GLP-1 Tracker: Wegovy pill numbers show its appeal

May 22, 2026 10:36am